Refine
Has Fulltext
- yes (36)
Is part of the Bibliography
- yes (36)
Year of publication
Document Type
- Journal article (36)
Language
- English (36) (remove)
Keywords
- echocardiography (7)
- myocardial infarction (6)
- heart failure (5)
- impact (3)
- inflammation (3)
- mortality (3)
- prognosis (3)
- Germany (2)
- TAVI (2)
- acute heart failure (2)
- amyloidosis (2)
- cardiomyopathy (2)
- cardiovascular magnetic resonance (2)
- chronic kidney disease (2)
- deformation (2)
- depression (2)
- ejection fraction (2)
- heart (2)
- left ventricular ejection fraction (2)
- morbidity (2)
- multicenter (2)
- outcomes (2)
- replacement (2)
- sizing (2)
- therapy (2)
- 2-dimensional speckle tracking (1)
- ACC/AHA classification (1)
- ARDS (acute respiratory distress syndrome) (1)
- Anderson-Fabry Disease (1)
- B cells (1)
- COPD diagnosis (1)
- COVID-19 (1)
- CardioMEMS™ HF system (1)
- Cardiovascular magnetic-resonance (1)
- Chronic heart-failure (1)
- Coronary artery disease (1)
- D313Y genotype (1)
- Desmoplakin (1)
- Disaster response (1)
- Enzyme replacement therapy (1)
- Fabry cardiomyopathy (1)
- Fabry disease (1)
- Fabry nephropathy (1)
- Fabry-associated pain (1)
- GOLD (1)
- Guidelines (1)
- Hospital emergency plan (1)
- Hypertrophic cardiomyopathy (1)
- Impella (1)
- Juvenile biventricular cardiomyopathy (1)
- Management (1)
- Manifestation (1)
- Mass critical care (1)
- Medizin (1)
- Myocardial fibrosis (1)
- Non‐ischaemic cardiogenic shock (1)
- Pain (1)
- Palmoplantar keratoderma (1)
- Prevalence (1)
- Prognostic impact (1)
- Risk-factors (1)
- SARS-CoV-2 (1)
- SCORE (1)
- ST-elevation myocardial infarction (1)
- Septal bulge (1)
- T cells (1)
- Task force (1)
- Valvular heart-desease (1)
- Ventricular-arrhythmias (1)
- accelerated atherosclerosis (1)
- adaptive immune response (1)
- anaemia (1)
- anatomy (1)
- aneurysm (1)
- anti-myocardial (1)
- antibodies (1)
- anxiety (1)
- aortic valve stenosis (AS) (1)
- apolipoprotein E (1)
- apoptosis (1)
- arterial stiffening (1)
- atherosclerosis (1)
- autoantibody (1)
- awareness (1)
- biomarker (1)
- blood (1)
- blood coagulation factor XIII (1)
- blood pressure monitoring (1)
- body weight (1)
- bull’s eye plot (1)
- calcification (1)
- calcium imaging (1)
- cardiac amyloidosis (1)
- cardiac magnetic resonance imaging (1)
- cardiac transplantation (1)
- cardiac ventricles (1)
- carotid artery disease (1)
- case report (1)
- chronic heart failure (1)
- clinical manifestations (1)
- comorbidity (1)
- complex (1)
- coronary artery disease (1)
- coronary heart disease (1)
- cryptogenic stroke (1)
- cytokines (1)
- death rates (1)
- deficient mice (1)
- diagnosis (1)
- diagnostic medicine (1)
- diastolic dysfunction (1)
- dimensions (1)
- disease (1)
- dobutamine stress echocardiography (1)
- double knockout mice (1)
- endothelial cell interactions (1)
- enzyme-linked immunoassays (1)
- euroaspire (1)
- extracellular matrix (1)
- extracellular matrix remodeling (1)
- fabry disease (1)
- fatal cardiovascular disease (1)
- fibrosis (1)
- guideline adherence (1)
- guideline implementation (1)
- guidelines (1)
- haemodynamic monitoring (1)
- healing and remodelling processes (1)
- health care (1)
- health‐related quality of life (1)
- heart disease (1)
- heart failure with mid-range ejection fraction (1)
- heart failure with reduced ejection fraction (1)
- heart rate (1)
- hypertension (1)
- hypertrophic cardiomyopathy (1)
- identification (1)
- in vivo (1)
- inherited metabolic disorders (1)
- intensive care medicine (1)
- kidneys (1)
- left ventricular hypertrophy (1)
- left ventricular thrombusv (1)
- lesion formation (1)
- leukocyte adhesion (1)
- lipoxygenase (1)
- low-gradient AS (1)
- lower limit of normal (1)
- magnetic resonance imaging (1)
- management (1)
- memory B cells (1)
- mice (1)
- mild (1)
- mineralocorticoid antagonist (1)
- multidetector computed-tomography (1)
- myocardial fibrosis (1)
- myocardium (1)
- natriuretic peptide (1)
- neutrophils (1)
- nitric oxide synthase (1)
- pandemia (1)
- paravalvular regurgitation (1)
- pharmacotherapy (1)
- platelet adhesion (1)
- preserved ejection fraction (1)
- pseudo-severe AS (1)
- public health (1)
- quality of life (1)
- recommendations (1)
- recovery (1)
- regression analysis (1)
- regurgitation (1)
- right ventricular dysfunction (1)
- root (1)
- sex differences (1)
- speckle tracking imaging (1)
- statins (1)
- stem cell transplantation (1)
- stenosis (1)
- surgical and invasive medical procedures (1)
- tomography (1)
- troponin T (1)
- validation (1)
- vascular surgery (1)
Institute
- Medizinische Klinik und Poliklinik I (32)
- Deutsches Zentrum für Herzinsuffizienz (DZHI) (14)
- Institut für Klinische Epidemiologie und Biometrie (5)
- Institut für diagnostische und interventionelle Radiologie (Institut für Röntgendiagnostik) (5)
- Institut für Pharmakologie und Toxikologie (3)
- Klinik und Poliklinik für Anästhesiologie (ab 2004) (3)
- Medizinische Klinik und Poliklinik II (3)
- Institut für Virologie und Immunbiologie (2)
- Klinik und Poliklinik für Psychiatrie, Psychosomatik und Psychotherapie (2)
- Klinik und Poliklinik für Thorax-, Herz- u. Thorakale Gefäßchirurgie (2)
Background:
Accurate preoperative assessment of the aortic annulus dimension is crucial for successful transcatheter aortic valve implantation (TAVI). In this study we validated a new method using two-dimensional transesophageal echocardiography (2D-TEE) for measurement of the aortic annulus prior to TAVI.
Methods:
We analysed 124 patients who underwent successful TAVI using a self-expandable prosthesis, divided equally into two groups; in the study group we used the cross sectional short axis 2D-TEE for measurement of the aortic annulus and in the control group we used the long axis 2D-TEE.
Results:
Both groups were comparable regarding the clinical parameters. On the other hand, patients in the study group had less left ventricular ejection fraction (38.9 % versus 45.6 %, p = 0.01). The aortic valve annulus was, although not statistically significant, smaller in the study group (21.58 versus 23.28 mm, p = 0.25). Post procedural quantification of the aortic regurgitation revealed that only one patient in both groups had severe aortic regurgitation (AR), in this patient the valve was implanted deep. The incidence of significant AR was higher in the control group (29.0 % versus 12.9 %, p = 0.027).
Conclusions:
Sizing of the aortic valve annulus using cross-sectional 2D-TEE offers a safe and plausible method for patients undergoing TAVI using the self-expandable prosthesis and is significantly superior to using long axis 2D-TEE.
Background: Accurate preoperative assessment of the aortic annulus dimension is crucial for successful transcatheter aortic valve implantation (TAVI). In this study we examined the accuracy of a novel method using two-dimensional transesophageal echocardiography (2D-TEE) for measurement of the aortic annulus.
Methods: We evaluated the theoretical impact of the measurement of the annulus diameter and area using the circumcircle of a triangle method on the decision to perform the procedure and choice of the prosthesis size. Results: Sixty-three consecutive patients were scheduled for TAVI. Mean age was 82 +/- 4 years, and 25 patients (55.6 %) were female. Mean aortic annulus diameter was 20.3 +/- 2.2 mm assessed by TEE on the mid-esophageal long-axis view and 23.9 +/- 2.3 mm using CT (p < 0.001). There was a tendency for the TEE derived areas using the new method to be higher (p < 0.001). The TEE measurements were on average 42.33 mm(2) higher than the CT measurements without an evidence of a systematic over-or under-sizing (p = 1.00). Agreement between TEE and CT chosen valve sizes was good overall (kappa = 0.67 and weighted kappa = 0.71). For patients who turned out to have no AR, the two methods agreed in 84.6 % of patients.
Conclusions: CT remanis the gold standard in sizing of the aortic valve annulus. Nevertheless, sizing of the aortic valve annulus using TEE derived area may be helpful. The impact of integration of this method in the algorithm of aortic annulus sizing on the outcome of patients undergoing TAVI should be examined in future studies.
Patients with genetic cardiomyopathy that involves myocardial hypertrophy often develop clinically relevant arrhythmias that increase the risk of sudden death. Consequently, guidelines for medical device therapy were established for hypertrophic cardiomyopathy, but not for conditions with only anecdotal evidence of arrhythmias, like Fabry cardiomyopathy. Patients with Fabry cardiomyopathy progressively develop myocardial fibrosis, and sudden cardiac death occurs regularly. Because 24-hour Holier electrocardiograms (ECGs) might not detect clinically important arrhythmias, we tested an implanted loop recorder for continuous heart rhythm surveillance and determined its impact on therapy. This prospective study included 16 patients (12 men) with advanced Fabry cardiomyopathy, relevant hypertrophy, and replacement fibrosis in "loco typico." No patients previously exhibited clinically relevant arrhythmias on Holier ECGs. Patients received an implantable loop recorder and were prospectively followed with telemedicine for a median of 1.2 years (range 0.3 to 2.0 years). The primary end point was a clinically meaningful event, which required a therapy change, captured with the loop recorder. Patients submitted data regularly (14 +/- 11 times per month). During follow-up, 21 events were detected (including 4 asystole, i.e., ECG pauses >= 3 seconds) and 7 bradycardia events; 5 episodes of intermittent atrial fibrillation (>3 minutes) and 5 episodes of ventricular tachycardia (3 sustained and 2 nonsustained). Subsequently, as defined in the primary end point, 15 events leaded to a change of therapy. These patients required therapy with a pacemaker or cardioverter defibrillator implantation and/or anticoagulation therapy for atrial fibrillation. In conclusion, clinically relevant arrhythmias that require further device and/or medical therapy are often missed with Holier ECGs in patients with advanced stage Fabry cardiomyopathy, but they can be detected by telemonitoring with an implantable loop recorder.
Two sons of a consanguineous marriage developed biventricular cardiomyopathy. One boy died of severe heart failure at the age of 6 years, the other was transplanted because of severe heart failure at the age of 10 years. In addition, focal palmoplantar keratoderma and woolly hair were apparent in both boys. As similar phenotypes have been described in Naxos disease and Carvajal syndrome, respectively, the genes for plakoglobin (JUP) and desmoplakin (DSP) were screened for mutations using direct genomic sequencing. A novel homozygous 2 bp deletion was identified in an alternatively spliced region of DSP. The deletion 5208_5209delAG led to a frameshift downstream of amino acid 1,736 with a premature truncation of the predominant cardiac isoform DSP-1. This novel homozygous truncating mutation in the isoform-1 specific region of the DSP C-terminus caused Carvajal syndrome comprising severe early-onset heart failure with features of non-compaction cardiomyopathy, woolly hair and an acantholytic form of palmoplantar keratoderma in our patient. Congenital hair abnormality and manifestation of the cutaneous phenotype in toddler age can help to identify children at risk for cardiac death.
Mass critical care caused by the severe acute respiratory syndrome corona virus 2 pandemic poses an extreme challenge to hospitals. The primary goal of hospital disaster preparedness and response is to maintain conventional or contingency care for as long as possible. Crisis care must be delayed as long as possible by appropriate measures. Increasing the intensive care unit (ICU) capacities is essential. In order to adjust surge capacity, the reduction of planned, elective patient care is an adequate response. However, this involves numerous problems that must be solved with a sense of proportion. This paper summarises preparedness and response measures recommended to acute care hospitals.
Functional versus morphological assessment of vascular age in patients with coronary heart disease
(2021)
Communicating cardiovascular risk based on individual vascular age (VA) is a well acknowledged concept in patient education and disease prevention. VA may be derived functionally, e.g. by measurement of pulse wave velocity (PWV), or morphologically, e.g. by assessment of carotid intima-media thickness (cIMT). The purpose of this study was to investigate whether both approaches produce similar results. Within the context of the German subset of the EUROASPIRE IV survey, 501 patients with coronary heart disease underwent (a) oscillometric PWV measurement at the aortic, carotid-femoral and brachial-ankle site (PWVao, PWVcf, PWVba) and derivation of the aortic augmentation index (AIao); (b) bilateral cIMT assessment by high-resolution ultrasound at three sites (common, bulb, internal). Respective VA was calculated using published equations. According to VA derived from PWV, most patients exhibited values below chronological age indicating a counterintuitive healthier-than-anticipated vascular status: for VA(PWVao) in 68% of patients; for VA\(_{AIao}\) in 52% of patients. By contrast, VA derived from cIMT delivered opposite results: e.g. according to VA\(_{total-cIMT}\) accelerated vascular aging in 75% of patients. To strengthen the concept of VA, further efforts are needed to better standardise the current approaches to estimate VA and, thereby, to improve comparability and clinical utility.